

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.33281211 |
| 2 | DNA deamination (GO:0045006) | 5.58337919 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 4.76111061 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 4.76111061 |
| 5 | tryptophan catabolic process (GO:0006569) | 4.76111061 |
| 6 | L-fucose catabolic process (GO:0042355) | 4.73546801 |
| 7 | fucose catabolic process (GO:0019317) | 4.73546801 |
| 8 | L-fucose metabolic process (GO:0042354) | 4.73546801 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.70183454 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.63663939 |
| 11 | indolalkylamine metabolic process (GO:0006586) | 4.30869137 |
| 12 | cellular ketone body metabolic process (GO:0046950) | 4.17958350 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 4.13494206 |
| 14 | viral transcription (GO:0019083) | 4.11818073 |
| 15 | translational termination (GO:0006415) | 4.01274765 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.01000028 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 3.94745239 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.91299233 |
| 19 | proteasome assembly (GO:0043248) | 3.88911739 |
| 20 | ketone body metabolic process (GO:1902224) | 3.81501397 |
| 21 | protein targeting to ER (GO:0045047) | 3.80996267 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 3.79912602 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.76720024 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.72772886 |
| 25 | rRNA modification (GO:0000154) | 3.67147426 |
| 26 | protein localization to endoplasmic reticulum (GO:0070972) | 3.66470682 |
| 27 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.65807083 |
| 28 | translational elongation (GO:0006414) | 3.62635696 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.60797277 |
| 30 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.57283023 |
| 31 | translational initiation (GO:0006413) | 3.54708490 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.50482729 |
| 33 | sulfation (GO:0051923) | 3.43180248 |
| 34 | maturation of SSU-rRNA (GO:0030490) | 3.41081985 |
| 35 | indole-containing compound metabolic process (GO:0042430) | 3.38396631 |
| 36 | cellular biogenic amine catabolic process (GO:0042402) | 3.37162038 |
| 37 | amine catabolic process (GO:0009310) | 3.37162038 |
| 38 | behavioral response to ethanol (GO:0048149) | 3.31992337 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31506815 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.29751861 |
| 41 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.29666151 |
| 42 | translation (GO:0006412) | 3.26833683 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 3.26792899 |
| 44 | oxidative demethylation (GO:0070989) | 3.26623530 |
| 45 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.25234445 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.24732048 |
| 47 | regulation of hippo signaling (GO:0035330) | 3.23890766 |
| 48 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.22712286 |
| 49 | metallo-sulfur cluster assembly (GO:0031163) | 3.22174315 |
| 50 | iron-sulfur cluster assembly (GO:0016226) | 3.22174315 |
| 51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.21418325 |
| 52 | reflex (GO:0060004) | 3.20122211 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 3.19921578 |
| 54 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.18416950 |
| 55 | detection of light stimulus involved in visual perception (GO:0050908) | 3.18416950 |
| 56 | ribosomal large subunit biogenesis (GO:0042273) | 3.16461634 |
| 57 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.16203650 |
| 58 | drug catabolic process (GO:0042737) | 3.15961398 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.15366833 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.15366833 |
| 61 | viral life cycle (GO:0019058) | 3.14288909 |
| 62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.13973154 |
| 63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.13973154 |
| 64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.13973154 |
| 65 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.13891694 |
| 66 | exogenous drug catabolic process (GO:0042738) | 3.13391211 |
| 67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.13098959 |
| 68 | negative regulation of ligase activity (GO:0051352) | 3.13098959 |
| 69 | amino acid salvage (GO:0043102) | 3.12618040 |
| 70 | L-methionine salvage (GO:0071267) | 3.12618040 |
| 71 | L-methionine biosynthetic process (GO:0071265) | 3.12618040 |
| 72 | regulation of mitochondrial translation (GO:0070129) | 3.12025457 |
| 73 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.11974332 |
| 74 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.10298397 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.10298397 |
| 76 | response to pheromone (GO:0019236) | 3.09975455 |
| 77 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.08306423 |
| 78 | NAD biosynthetic process (GO:0009435) | 3.07988853 |
| 79 | rRNA methylation (GO:0031167) | 3.05950713 |
| 80 | cellular protein complex disassembly (GO:0043624) | 3.04824625 |
| 81 | ribosome biogenesis (GO:0042254) | 3.02654023 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.01946831 |
| 83 | rRNA processing (GO:0006364) | 3.01659364 |
| 84 | piRNA metabolic process (GO:0034587) | 3.01309483 |
| 85 | negative regulation of telomere maintenance (GO:0032205) | 3.00411838 |
| 86 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.00158053 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.00096634 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00096634 |
| 89 | cellular response to ATP (GO:0071318) | 2.98901373 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.97422344 |
| 91 | immunoglobulin mediated immune response (GO:0016064) | 2.97307291 |
| 92 | nonmotile primary cilium assembly (GO:0035058) | 2.94773653 |
| 93 | negative regulation of mast cell activation (GO:0033004) | 2.94230274 |
| 94 | neuronal action potential (GO:0019228) | 2.94219659 |
| 95 | primary amino compound metabolic process (GO:1901160) | 2.89860612 |
| 96 | neural tube formation (GO:0001841) | 2.89496833 |
| 97 | rRNA metabolic process (GO:0016072) | 2.88790855 |
| 98 | gamma-aminobutyric acid transport (GO:0015812) | 2.88446635 |
| 99 | sphingoid metabolic process (GO:0046519) | 2.88341709 |
| 100 | ribosome assembly (GO:0042255) | 2.88062460 |
| 101 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.87569816 |
| 102 | serotonin metabolic process (GO:0042428) | 2.84229362 |
| 103 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.83586107 |
| 104 | DNA methylation involved in gamete generation (GO:0043046) | 2.82765416 |
| 105 | positive regulation of ligase activity (GO:0051351) | 2.81043126 |
| 106 | neutrophil activation involved in immune response (GO:0002283) | 2.80334022 |
| 107 | platelet dense granule organization (GO:0060155) | 2.77944886 |
| 108 | response to interferon-beta (GO:0035456) | 2.77276191 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76481718 |
| 110 | respiratory burst (GO:0045730) | 2.75407985 |
| 111 | kidney morphogenesis (GO:0060993) | 2.74821737 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74768302 |
| 113 | benzene-containing compound metabolic process (GO:0042537) | 2.73558591 |
| 114 | folic acid metabolic process (GO:0046655) | 2.73489795 |
| 115 | signal peptide processing (GO:0006465) | 2.73427030 |
| 116 | regulation of pigment cell differentiation (GO:0050932) | 2.73140495 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72997750 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72997750 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72997750 |
| 120 | aromatic amino acid family metabolic process (GO:0009072) | 2.71875942 |
| 121 | B cell mediated immunity (GO:0019724) | 2.71469987 |
| 122 | endosome to pigment granule transport (GO:0043485) | 2.71323240 |
| 123 | endosome to melanosome transport (GO:0035646) | 2.71323240 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.71246560 |
| 125 | reciprocal meiotic recombination (GO:0007131) | 2.70879393 |
| 126 | reciprocal DNA recombination (GO:0035825) | 2.70879393 |
| 127 | positive regulation of developmental pigmentation (GO:0048087) | 2.69287339 |
| 128 | cornea development in camera-type eye (GO:0061303) | 2.66914881 |
| 129 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.66698014 |
| 130 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.65655466 |
| 131 | cellular component biogenesis (GO:0044085) | 2.64993127 |
| 132 | ubiquinone biosynthetic process (GO:0006744) | 2.64830588 |
| 133 | neurotransmitter metabolic process (GO:0042133) | 2.63956782 |
| 134 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.63491611 |
| 135 | positive regulation of cell cycle arrest (GO:0071158) | 2.62609073 |
| 136 | positive regulation of fatty acid oxidation (GO:0046321) | 2.61587697 |
| 137 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61437665 |
| 138 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60714578 |
| 139 | positive regulation of fatty acid transport (GO:2000193) | 2.59772216 |
| 140 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.59767502 |
| 141 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.59597841 |
| 142 | spinal cord motor neuron differentiation (GO:0021522) | 2.59406788 |
| 143 | synaptic transmission, cholinergic (GO:0007271) | 2.59051527 |
| 144 | protein import into peroxisome matrix (GO:0016558) | 2.58445037 |
| 145 | S-adenosylmethionine metabolic process (GO:0046500) | 2.57530351 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57329289 |
| 147 | rhodopsin mediated signaling pathway (GO:0016056) | 2.56942287 |
| 148 | protein targeting to membrane (GO:0006612) | 2.56884989 |
| 149 | establishment of protein localization to mitochondrion (GO:0072655) | 2.56759905 |
| 150 | protein targeting to mitochondrion (GO:0006626) | 2.56741723 |
| 151 | protein complex disassembly (GO:0043241) | 2.55751835 |
| 152 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55199942 |
| 153 | methionine biosynthetic process (GO:0009086) | 2.54570261 |
| 154 | purine nucleobase biosynthetic process (GO:0009113) | 2.54291064 |
| 155 | fucosylation (GO:0036065) | 2.53478203 |
| 156 | flavonoid metabolic process (GO:0009812) | 2.53161844 |
| 157 | peristalsis (GO:0030432) | 2.53103376 |
| 158 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.52397893 |
| 159 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.52397893 |
| 160 | protein complex biogenesis (GO:0070271) | 2.52362830 |
| 161 | sulfate transmembrane transport (GO:1902358) | 2.51993642 |
| 162 | cellular response to interferon-beta (GO:0035458) | 2.51935375 |
| 163 | nephron epithelium morphogenesis (GO:0072088) | 2.51765533 |
| 164 | nephron tubule morphogenesis (GO:0072078) | 2.51765533 |
| 165 | termination of RNA polymerase III transcription (GO:0006386) | 2.51447510 |
| 166 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.51447510 |
| 167 | auditory receptor cell stereocilium organization (GO:0060088) | 2.50501191 |
| 168 | response to peptidoglycan (GO:0032494) | 2.49859829 |
| 169 | epithelial cilium movement (GO:0003351) | 2.49621989 |
| 170 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.49392588 |
| 171 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.49392588 |
| 172 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.49392588 |
| 173 | photoreceptor cell maintenance (GO:0045494) | 2.49328398 |
| 174 | ubiquinone metabolic process (GO:0006743) | 2.49272713 |
| 175 | cilium morphogenesis (GO:0060271) | 2.48355588 |
| 176 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.47852807 |
| 177 | sequestering of actin monomers (GO:0042989) | 2.47622438 |
| 178 | respiratory chain complex IV assembly (GO:0008535) | 2.46983439 |
| 179 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.46310332 |
| 180 | nucleobase biosynthetic process (GO:0046112) | 2.46252659 |
| 181 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.46078058 |
| 182 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.45835957 |
| 183 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.45196647 |
| 184 | somite rostral/caudal axis specification (GO:0032525) | 2.44995306 |
| 185 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.42915004 |
| 186 | macromolecular complex disassembly (GO:0032984) | 2.42645874 |
| 187 | DNA strand elongation (GO:0022616) | 2.41074723 |
| 188 | type I interferon signaling pathway (GO:0060337) | 2.40684339 |
| 189 | cellular response to type I interferon (GO:0071357) | 2.40684339 |
| 190 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.40216932 |
| 191 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.39747985 |
| 192 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.39055247 |
| 193 | DNA replication initiation (GO:0006270) | 2.38553668 |
| 194 | cellular response to zinc ion (GO:0071294) | 2.37677929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.93498131 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.71776788 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.51017699 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.31312429 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.19686206 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15149336 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.02952425 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.98183257 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.96145620 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93735798 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.71887315 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.70555843 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.66706195 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60172024 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.58375652 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.57659288 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.56663694 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49428228 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.46642143 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39860450 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38330754 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.33635300 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.27759969 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19460211 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18503404 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16277176 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15656121 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15065616 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14052281 |
| 30 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.09007099 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.08294505 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07971331 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.06258599 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96386741 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.95266552 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94825212 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92224543 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.90622872 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.88923536 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88476783 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87778341 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82415370 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80938832 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79235534 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.78447515 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.77881724 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.77367748 |
| 48 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.76495046 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74114940 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.72454415 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.71023518 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70569307 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69717719 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69574587 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67604723 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66569626 |
| 57 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65138191 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.64565881 |
| 59 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64405788 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64314688 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64047470 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60933617 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.59622049 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57621131 |
| 65 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57255915 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56091667 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56090713 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55899599 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55804716 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53881095 |
| 71 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.53548646 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53383158 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53308837 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.53308837 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52966972 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.52302394 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52013699 |
| 78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51541963 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50473970 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49875764 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49228865 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49119564 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46737490 |
| 84 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46180676 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45929277 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45929277 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45186223 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44994029 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44456869 |
| 90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42885427 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42469469 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41971360 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41605339 |
| 94 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40800266 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39786169 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39424232 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39097496 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39077607 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.37983590 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.37983590 |
| 101 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36834766 |
| 102 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.36109651 |
| 103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35914619 |
| 104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35684243 |
| 105 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35341709 |
| 106 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35333811 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34799940 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32327323 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32254495 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.32161778 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31281217 |
| 112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31033129 |
| 113 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31033129 |
| 114 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30589679 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30461079 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28069829 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27853949 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27639419 |
| 119 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.25450969 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22568685 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21868470 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21851773 |
| 123 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21733632 |
| 124 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21686768 |
| 125 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21066471 |
| 126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21019469 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20771186 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19477769 |
| 129 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18847090 |
| 130 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18832540 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18442480 |
| 132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18413264 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18368146 |
| 134 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18307244 |
| 135 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17791653 |
| 136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17383048 |
| 137 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16773082 |
| 138 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16732011 |
| 139 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15881054 |
| 140 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15488287 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.14707251 |
| 142 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12633656 |
| 143 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12312080 |
| 144 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12234667 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 1.12220605 |
| 146 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11964734 |
| 147 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11871346 |
| 148 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11471263 |
| 149 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11231784 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11078190 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10742766 |
| 152 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10629683 |
| 153 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10531468 |
| 154 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10157184 |
| 155 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09851222 |
| 156 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09640205 |
| 157 | MYB_26560356_Chip-Seq_TH2_Human | 1.09427283 |
| 158 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08935866 |
| 159 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08583416 |
| 160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08374915 |
| 161 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08149168 |
| 162 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07419947 |
| 163 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07294498 |
| 164 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06979418 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06489547 |
| 166 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05147006 |
| 167 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04936928 |
| 168 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04004017 |
| 169 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03840982 |
| 170 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03624254 |
| 171 | MYB_26560356_Chip-Seq_TH1_Human | 1.03298188 |
| 172 | MAF_26560356_Chip-Seq_TH2_Human | 1.03148215 |
| 173 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03006997 |
| 174 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02294465 |
| 175 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02016613 |
| 176 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01538048 |
| 177 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01506720 |
| 178 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01491146 |
| 179 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01329760 |
| 180 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00357536 |
| 181 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00337784 |
| 182 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00045238 |
| 183 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99414601 |
| 184 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99184786 |
| 185 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98705531 |
| 186 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98476104 |
| 187 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98062615 |
| 188 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97827382 |
| 189 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97717890 |
| 190 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97406876 |
| 191 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97183668 |
| 192 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96865519 |
| 193 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96678618 |
| 194 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96360088 |
| 195 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95064846 |
| 196 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94699220 |
| 197 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.94036909 |
| 198 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93798244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.50747670 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.36177574 |
| 3 | MP0009840_abnormal_foam_cell | 3.34028030 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.11323854 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.07419221 |
| 6 | MP0003136_yellow_coat_color | 3.01388921 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.98815557 |
| 8 | MP0003646_muscle_fatigue | 2.94183791 |
| 9 | MP0006082_CNS_inflammation | 2.68382886 |
| 10 | MP0009785_altered_susceptibility_to | 2.62584976 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.60189654 |
| 12 | MP0009046_muscle_twitch | 2.57291672 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54659917 |
| 14 | MP0005671_abnormal_response_to | 2.53252588 |
| 15 | MP0003186_abnormal_redox_activity | 2.49805060 |
| 16 | MP0000685_abnormal_immune_system | 2.47931026 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.46361205 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.44947712 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.35775401 |
| 20 | MP0003436_decreased_susceptibility_to | 2.33259469 |
| 21 | MP0005025_abnormal_response_to | 2.29322417 |
| 22 | MP0001790_abnormal_immune_system | 2.26622319 |
| 23 | MP0005387_immune_system_phenotype | 2.26622319 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.21278767 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.15772221 |
| 26 | MP0002723_abnormal_immune_serum | 2.13869343 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.12770870 |
| 28 | MP0001800_abnormal_humoral_immune | 2.10995757 |
| 29 | MP0002102_abnormal_ear_morphology | 2.10477727 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 2.09326314 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.05034593 |
| 32 | MP0001853_heart_inflammation | 2.03807329 |
| 33 | MP0002876_abnormal_thyroid_physiology | 2.02382990 |
| 34 | MP0004142_abnormal_muscle_tone | 2.00700019 |
| 35 | MP0002653_abnormal_ependyma_morphology | 2.00392169 |
| 36 | MP0000427_abnormal_hair_cycle | 1.97668776 |
| 37 | MP0002419_abnormal_innate_immunity | 1.97037029 |
| 38 | MP0001819_abnormal_immune_cell | 1.93314144 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.92823864 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.92659003 |
| 41 | MP0009745_abnormal_behavioral_response | 1.90486085 |
| 42 | MP0004147_increased_porphyrin_level | 1.88194044 |
| 43 | MP0008872_abnormal_physiological_respon | 1.86055320 |
| 44 | MP0002938_white_spotting | 1.84624266 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.84091641 |
| 46 | MP0000490_abnormal_crypts_of | 1.82223123 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.80670002 |
| 48 | MP0002398_abnormal_bone_marrow | 1.76203799 |
| 49 | MP0002405_respiratory_system_inflammati | 1.73796850 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.73483132 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.71858157 |
| 52 | MP0000716_abnormal_immune_system | 1.70017978 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.69419909 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.68670869 |
| 55 | MP0004885_abnormal_endolymph | 1.68042236 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.68025089 |
| 57 | MP0002735_abnormal_chemical_nociception | 1.67445130 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.66601700 |
| 59 | MP0005171_absent_coat_pigmentation | 1.65214036 |
| 60 | MP0005310_abnormal_salivary_gland | 1.64772524 |
| 61 | MP0002722_abnormal_immune_system | 1.63713802 |
| 62 | MP0005253_abnormal_eye_physiology | 1.62179732 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.61989693 |
| 64 | MP0002272_abnormal_nervous_system | 1.59002716 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.58740199 |
| 66 | MP0000858_altered_metastatic_potential | 1.56761023 |
| 67 | MP0003077_abnormal_cell_cycle | 1.56502689 |
| 68 | MP0002429_abnormal_blood_cell | 1.54089102 |
| 69 | MP0008469_abnormal_protein_level | 1.53609685 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.52613155 |
| 71 | MP0004133_heterotaxia | 1.51334236 |
| 72 | MP0002736_abnormal_nociception_after | 1.51188881 |
| 73 | MP0000383_abnormal_hair_follicle | 1.48688223 |
| 74 | MP0003724_increased_susceptibility_to | 1.48459728 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.47746505 |
| 76 | MP0002064_seizures | 1.47495685 |
| 77 | MP0004742_abnormal_vestibular_system | 1.47178917 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.46137173 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 1.44560581 |
| 80 | MP0004947_skin_inflammation | 1.44185261 |
| 81 | MP0005365_abnormal_bile_salt | 1.43776828 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 1.40411957 |
| 83 | MP0003011_delayed_dark_adaptation | 1.39991318 |
| 84 | MP0000343_altered_response_to | 1.39307181 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.38445492 |
| 86 | MP0003045_fibrosis | 1.36414202 |
| 87 | MP0003303_peritoneal_inflammation | 1.35061853 |
| 88 | MP0003252_abnormal_bile_duct | 1.34749051 |
| 89 | MP0001486_abnormal_startle_reflex | 1.34590660 |
| 90 | MP0010094_abnormal_chromosome_stability | 1.33677751 |
| 91 | MP0002166_altered_tumor_susceptibility | 1.32962884 |
| 92 | MP0004924_abnormal_behavior | 1.29654273 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.29654273 |
| 94 | MP0001545_abnormal_hematopoietic_system | 1.28849710 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 1.28849710 |
| 96 | MP0002095_abnormal_skin_pigmentation | 1.27968661 |
| 97 | MP0003172_abnormal_lysosome_physiology | 1.27224394 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 1.27005675 |
| 99 | MP0002067_abnormal_sensory_capabilities | 1.24465534 |
| 100 | MP0001970_abnormal_pain_threshold | 1.23177814 |
| 101 | MP0002019_abnormal_tumor_incidence | 1.22019309 |
| 102 | MP0010386_abnormal_urinary_bladder | 1.21877275 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 1.21301868 |
| 104 | MP0002733_abnormal_thermal_nociception | 1.21202976 |
| 105 | MP0003283_abnormal_digestive_organ | 1.20920911 |
| 106 | MP0001533_abnormal_skeleton_physiology | 1.20786108 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 1.20660634 |
| 108 | MP0000358_abnormal_cell_content/ | 1.20316007 |
| 109 | MP0003195_calcinosis | 1.20019111 |
| 110 | MP0008932_abnormal_embryonic_tissue | 1.19381870 |
| 111 | MP0002006_tumorigenesis | 1.19348634 |
| 112 | MP0002928_abnormal_bile_duct | 1.16298407 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 1.14800231 |
| 114 | MP0002557_abnormal_social/conspecific_i | 1.14141015 |
| 115 | MP0003448_altered_tumor_morphology | 1.13176657 |
| 116 | MP0004130_abnormal_muscle_cell | 1.12421174 |
| 117 | MP0002160_abnormal_reproductive_system | 1.12130200 |
| 118 | MP0000703_abnormal_thymus_morphology | 1.11882855 |
| 119 | MP0003787_abnormal_imprinting | 1.11700337 |
| 120 | MP0001324_abnormal_eye_pigmentation | 1.11689189 |
| 121 | MP0000538_abnormal_urinary_bladder | 1.11031595 |
| 122 | MP0010329_abnormal_lipoprotein_level | 1.10727372 |
| 123 | MP0002933_joint_inflammation | 1.10579123 |
| 124 | MP0008058_abnormal_DNA_repair | 1.10351171 |
| 125 | MP0003866_abnormal_defecation | 1.09192446 |
| 126 | MP0000313_abnormal_cell_death | 1.07499630 |
| 127 | MP0002234_abnormal_pharynx_morphology | 1.07477323 |
| 128 | MP0002132_abnormal_respiratory_system | 1.06906637 |
| 129 | MP0008057_abnormal_DNA_replication | 1.05133299 |
| 130 | MP0005389_reproductive_system_phenotype | 1.04410531 |
| 131 | MP0008961_abnormal_basal_metabolism | 1.03272230 |
| 132 | MP0004510_myositis | 1.02684347 |
| 133 | MP0002063_abnormal_learning/memory/cond | 1.02474565 |
| 134 | MP0008260_abnormal_autophagy | 1.02024947 |
| 135 | MP0009643_abnormal_urine_homeostasis | 1.01279500 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 1.00945151 |
| 137 | MP0010307_abnormal_tumor_latency | 1.00287754 |
| 138 | MP0005332_abnormal_amino_acid | 1.00220801 |
| 139 | MP0005195_abnormal_posterior_eye | 1.00144390 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.99843971 |
| 141 | MP0002138_abnormal_hepatobiliary_system | 0.99233690 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.98006274 |
| 143 | MP0001764_abnormal_homeostasis | 0.97696308 |
| 144 | MP0001440_abnormal_grooming_behavior | 0.97333556 |
| 145 | MP0003635_abnormal_synaptic_transmissio | 0.96761321 |
| 146 | MP0003880_abnormal_central_pattern | 0.96316003 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.96270605 |
| 148 | MP0001984_abnormal_olfaction | 0.95811310 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.95187720 |
| 150 | MP0001905_abnormal_dopamine_level | 0.93688863 |
| 151 | MP0000609_abnormal_liver_physiology | 0.93372745 |
| 152 | MP0001873_stomach_inflammation | 0.91865467 |
| 153 | MP0005410_abnormal_fertilization | 0.91337999 |
| 154 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89990026 |
| 155 | MP0003718_maternal_effect | 0.89401737 |
| 156 | MP0005084_abnormal_gallbladder_morpholo | 0.88180693 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.87842384 |
| 158 | MP0002877_abnormal_melanocyte_morpholog | 0.87576637 |
| 159 | MP0005174_abnormal_tail_pigmentation | 0.87477727 |
| 160 | MP0000598_abnormal_liver_morphology | 0.86939383 |
| 161 | MP0008007_abnormal_cellular_replicative | 0.86149231 |
| 162 | MP0006292_abnormal_olfactory_placode | 0.85890738 |
| 163 | MP0005075_abnormal_melanosome_morpholog | 0.84877260 |
| 164 | MP0005448_abnormal_energy_balance | 0.83952275 |
| 165 | MP0002229_neurodegeneration | 0.83349876 |
| 166 | MP0000750_abnormal_muscle_regeneration | 0.82088225 |
| 167 | MP0001919_abnormal_reproductive_system | 0.81225727 |
| 168 | MP0008775_abnormal_heart_ventricle | 0.80034112 |
| 169 | MP0001502_abnormal_circadian_rhythm | 0.79560949 |
| 170 | MP0005423_abnormal_somatic_nervous | 0.79077965 |
| 171 | MP0006035_abnormal_mitochondrial_morpho | 0.78663914 |
| 172 | MP0001986_abnormal_taste_sensitivity | 0.77631737 |
| 173 | MP0003878_abnormal_ear_physiology | 0.76831803 |
| 174 | MP0005377_hearing/vestibular/ear_phenot | 0.76831803 |
| 175 | MP0002752_abnormal_somatic_nervous | 0.76404886 |
| 176 | MP0005670_abnormal_white_adipose | 0.76374651 |
| 177 | MP0004808_abnormal_hematopoietic_stem | 0.76276249 |
| 178 | MP0000372_irregular_coat_pigmentation | 0.76228629 |
| 179 | MP0005083_abnormal_biliary_tract | 0.75838528 |
| 180 | MP0003950_abnormal_plasma_membrane | 0.75449060 |
| 181 | MP0002693_abnormal_pancreas_physiology | 0.75007699 |
| 182 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74109109 |
| 183 | MP0004043_abnormal_pH_regulation | 0.73712575 |
| 184 | MP0000604_amyloidosis | 0.73416335 |
| 185 | MP0001730_embryonic_growth_arrest | 0.72952132 |
| 186 | MP0002136_abnormal_kidney_physiology | 0.72652947 |
| 187 | MP0000470_abnormal_stomach_morphology | 0.71994904 |
| 188 | MP0002638_abnormal_pupillary_reflex | 0.71601029 |
| 189 | MP0005023_abnormal_wound_healing | 0.70944080 |
| 190 | MP0009763_increased_sensitivity_to | 0.70614851 |
| 191 | MP0005636_abnormal_mineral_homeostasis | 0.70488579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.77977147 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.18620885 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 4.18267431 |
| 4 | Abnormality of midbrain morphology (HP:0002418) | 4.18267431 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.12920723 |
| 6 | Hyperventilation (HP:0002883) | 4.03563445 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.99684468 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.99360909 |
| 9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.95989405 |
| 10 | Abnormality of alanine metabolism (HP:0010916) | 3.95989405 |
| 11 | Hyperalaninemia (HP:0003348) | 3.95989405 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.95228820 |
| 13 | Nephronophthisis (HP:0000090) | 3.87186378 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84756038 |
| 15 | True hermaphroditism (HP:0010459) | 3.69711232 |
| 16 | Abnormality of the renal cortex (HP:0011035) | 3.64709271 |
| 17 | Abnormality of the renal medulla (HP:0100957) | 3.55097010 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.48219286 |
| 19 | Type II lissencephaly (HP:0007260) | 3.38872299 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.32459684 |
| 21 | Petechiae (HP:0000967) | 3.22496243 |
| 22 | Poor head control (HP:0002421) | 3.18571361 |
| 23 | IgM deficiency (HP:0002850) | 3.17149060 |
| 24 | Tubular atrophy (HP:0000092) | 3.16776341 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.13957374 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 3.13820226 |
| 27 | Pustule (HP:0200039) | 3.12534983 |
| 28 | Multiple enchondromatosis (HP:0005701) | 3.07820438 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 3.04921831 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02467715 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02467715 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02467715 |
| 33 | Reticulocytopenia (HP:0001896) | 3.00976996 |
| 34 | Genetic anticipation (HP:0003743) | 2.99250371 |
| 35 | Inability to walk (HP:0002540) | 2.95692926 |
| 36 | Medial flaring of the eyebrow (HP:0010747) | 2.93624715 |
| 37 | Large for gestational age (HP:0001520) | 2.93073921 |
| 38 | Cystic liver disease (HP:0006706) | 2.89930729 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.89338114 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.87705366 |
| 41 | Protruding tongue (HP:0010808) | 2.87169224 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.85071095 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.80480794 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77977622 |
| 45 | Microretrognathia (HP:0000308) | 2.77749352 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.76607608 |
| 47 | Cerebellar dysplasia (HP:0007033) | 2.74896924 |
| 48 | Chronic hepatic failure (HP:0100626) | 2.74195431 |
| 49 | Clumsiness (HP:0002312) | 2.73529104 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.72681408 |
| 51 | Progressive inability to walk (HP:0002505) | 2.71669928 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.69707509 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67020120 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.66185274 |
| 55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.66185274 |
| 56 | Concave nail (HP:0001598) | 2.65284731 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.64789594 |
| 58 | Polydipsia (HP:0001959) | 2.64789594 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.60635348 |
| 60 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57425129 |
| 61 | Abnormality of T cells (HP:0002843) | 2.56603877 |
| 62 | Amelogenesis imperfecta (HP:0000705) | 2.56245169 |
| 63 | Progressive muscle weakness (HP:0003323) | 2.54787248 |
| 64 | Fair hair (HP:0002286) | 2.53205158 |
| 65 | Pallor (HP:0000980) | 2.53069772 |
| 66 | Furrowed tongue (HP:0000221) | 2.52819316 |
| 67 | Congenital, generalized hypertrichosis (HP:0004540) | 2.51150965 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.50676411 |
| 69 | Pendular nystagmus (HP:0012043) | 2.49798696 |
| 70 | Gait imbalance (HP:0002141) | 2.48461015 |
| 71 | Hepatic necrosis (HP:0002605) | 2.45725014 |
| 72 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.44599218 |
| 73 | Exertional dyspnea (HP:0002875) | 2.42951224 |
| 74 | Chronic otitis media (HP:0000389) | 2.42012072 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.41639218 |
| 76 | Abnormality of the pons (HP:0007361) | 2.41209153 |
| 77 | Focal motor seizures (HP:0011153) | 2.39720112 |
| 78 | Rough bone trabeculation (HP:0100670) | 2.39607144 |
| 79 | Thrombocytosis (HP:0001894) | 2.39263833 |
| 80 | Hepatocellular necrosis (HP:0001404) | 2.38813861 |
| 81 | Increased serum ferritin (HP:0003281) | 2.37300207 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.37256872 |
| 83 | Decreased central vision (HP:0007663) | 2.36056923 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34651488 |
| 85 | Patellar aplasia (HP:0006443) | 2.34089021 |
| 86 | Lissencephaly (HP:0001339) | 2.33713461 |
| 87 | Lipid accumulation in hepatocytes (HP:0006561) | 2.33537587 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.32174998 |
| 89 | IgG deficiency (HP:0004315) | 2.31326081 |
| 90 | Macrocytic anemia (HP:0001972) | 2.31314534 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 2.30502536 |
| 92 | Keratoconus (HP:0000563) | 2.30429105 |
| 93 | Increased corneal curvature (HP:0100692) | 2.30429105 |
| 94 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29752432 |
| 95 | Oral leukoplakia (HP:0002745) | 2.29739728 |
| 96 | Broad-based gait (HP:0002136) | 2.29488821 |
| 97 | Hypoplasia of the pons (HP:0012110) | 2.29178599 |
| 98 | Cerebral hypomyelination (HP:0006808) | 2.27211696 |
| 99 | Renal cortical cysts (HP:0000803) | 2.27202850 |
| 100 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26416114 |
| 101 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26416114 |
| 102 | Recurrent skin infections (HP:0001581) | 2.25938728 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 2.24681706 |
| 104 | Recurrent viral infections (HP:0004429) | 2.24362216 |
| 105 | Birth length less than 3rd percentile (HP:0003561) | 2.24072696 |
| 106 | Axonal loss (HP:0003447) | 2.24070639 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23985869 |
| 108 | Increased CSF lactate (HP:0002490) | 2.23184958 |
| 109 | Nephrogenic diabetes insipidus (HP:0009806) | 2.22665367 |
| 110 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.22572463 |
| 111 | Aplastic anemia (HP:0001915) | 2.22520444 |
| 112 | Poikiloderma (HP:0001029) | 2.21105946 |
| 113 | Congenital hepatic fibrosis (HP:0002612) | 2.20977685 |
| 114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.20331051 |
| 115 | Bile duct proliferation (HP:0001408) | 2.19902065 |
| 116 | Abnormal biliary tract physiology (HP:0012439) | 2.19902065 |
| 117 | Acute necrotizing encephalopathy (HP:0006965) | 2.19741788 |
| 118 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.19440336 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 2.18738230 |
| 120 | Sclerocornea (HP:0000647) | 2.18543592 |
| 121 | Nausea (HP:0002018) | 2.18488208 |
| 122 | Type I transferrin isoform profile (HP:0003642) | 2.18260171 |
| 123 | Increased muscle lipid content (HP:0009058) | 2.18241004 |
| 124 | Hyperglycinuria (HP:0003108) | 2.18235197 |
| 125 | Trismus (HP:0000211) | 2.18197499 |
| 126 | Polyuria (HP:0000103) | 2.18124418 |
| 127 | Increased IgM level (HP:0003496) | 2.17866099 |
| 128 | Severe muscular hypotonia (HP:0006829) | 2.16953722 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 2.16604501 |
| 130 | Acute encephalopathy (HP:0006846) | 2.14386153 |
| 131 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12678474 |
| 132 | Absent/shortened dynein arms (HP:0200106) | 2.12678474 |
| 133 | 3-Methylglutaconic aciduria (HP:0003535) | 2.12675905 |
| 134 | Generalized hypopigmentation of hair (HP:0011358) | 2.11245779 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10711032 |
| 136 | Obstructive lung disease (HP:0006536) | 2.10711032 |
| 137 | Increased serum lactate (HP:0002151) | 2.10489239 |
| 138 | Dialeptic seizures (HP:0011146) | 2.10236820 |
| 139 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09984678 |
| 140 | Recurrent bronchitis (HP:0002837) | 2.08775443 |
| 141 | Myositis (HP:0100614) | 2.08414629 |
| 142 | Entropion (HP:0000621) | 2.07908873 |
| 143 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06614239 |
| 144 | Mucopolysacchariduria (HP:0008155) | 2.05551972 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05551972 |
| 146 | Agnosia (HP:0010524) | 2.04836447 |
| 147 | Lymphopenia (HP:0001888) | 2.04396199 |
| 148 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04134390 |
| 149 | Personality changes (HP:0000751) | 2.02778974 |
| 150 | Ketoacidosis (HP:0001993) | 2.02241061 |
| 151 | CNS demyelination (HP:0007305) | 2.02179966 |
| 152 | Chorioretinal atrophy (HP:0000533) | 2.02075065 |
| 153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00884263 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.98453685 |
| 155 | Renal Fanconi syndrome (HP:0001994) | 1.96900374 |
| 156 | Anencephaly (HP:0002323) | 1.95877283 |
| 157 | Ketosis (HP:0001946) | 1.93773421 |
| 158 | Combined immunodeficiency (HP:0005387) | 1.92752648 |
| 159 | Abnormal trabecular bone morphology (HP:0100671) | 1.92726757 |
| 160 | Hepatosplenomegaly (HP:0001433) | 1.92676511 |
| 161 | Cheilitis (HP:0100825) | 1.92508749 |
| 162 | Purpura (HP:0000979) | 1.91540125 |
| 163 | Genital tract atresia (HP:0001827) | 1.90318849 |
| 164 | Vaginal atresia (HP:0000148) | 1.89855443 |
| 165 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89764450 |
| 166 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89764450 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89764450 |
| 168 | Hypoplasia of the thymus (HP:0000778) | 1.89748467 |
| 169 | Nasal polyposis (HP:0100582) | 1.89673198 |
| 170 | Abnormality of the anterior horn cell (HP:0006802) | 1.89135121 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.89135121 |
| 172 | Tachypnea (HP:0002789) | 1.88939291 |
| 173 | Breast hypoplasia (HP:0003187) | 1.88645481 |
| 174 | Vertebral compression fractures (HP:0002953) | 1.87538065 |
| 175 | Focal seizures (HP:0007359) | 1.87024186 |
| 176 | Febrile seizures (HP:0002373) | 1.85664391 |
| 177 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82740549 |
| 178 | Male pseudohermaphroditism (HP:0000037) | 1.82073502 |
| 179 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82017280 |
| 180 | Widely spaced teeth (HP:0000687) | 1.81697989 |
| 181 | Hemiparesis (HP:0001269) | 1.81160492 |
| 182 | Poor coordination (HP:0002370) | 1.80271115 |
| 183 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79371554 |
| 184 | Absent speech (HP:0001344) | 1.77117062 |
| 185 | Stomach cancer (HP:0012126) | 1.76893718 |
| 186 | Abnormal urine output (HP:0012590) | 1.71624854 |
| 187 | Pachygyria (HP:0001302) | 1.71386486 |
| 188 | Tubulointerstitial fibrosis (HP:0005576) | 1.70322788 |
| 189 | Abnormality of renin-angiotensin system (HP:0000847) | 1.67300115 |
| 190 | Partial agenesis of the corpus callosum (HP:0001338) | 1.66772326 |
| 191 | Postaxial foot polydactyly (HP:0001830) | 1.66291895 |
| 192 | Retinitis pigmentosa (HP:0000510) | 1.65942874 |
| 193 | Macular degeneration (HP:0000608) | 1.65325876 |
| 194 | Hypothermia (HP:0002045) | 1.63465410 |
| 195 | Abnormality of glycine metabolism (HP:0010895) | 1.61248472 |
| 196 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.61248472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.65294532 |
| 2 | NME2 | 5.06197398 |
| 3 | BMPR1B | 3.87766317 |
| 4 | ADRBK2 | 3.39855368 |
| 5 | MAP4K1 | 3.28851854 |
| 6 | BUB1 | 3.21667786 |
| 7 | INSRR | 3.17688105 |
| 8 | BLK | 2.88411671 |
| 9 | ZAK | 2.85884179 |
| 10 | WNK4 | 2.72995715 |
| 11 | PIM2 | 2.60113934 |
| 12 | TESK2 | 2.55287233 |
| 13 | IRAK3 | 2.54068101 |
| 14 | GRK1 | 2.51372582 |
| 15 | SCYL2 | 2.50063944 |
| 16 | STK16 | 2.24993768 |
| 17 | WEE1 | 2.23516657 |
| 18 | EIF2AK1 | 2.20679937 |
| 19 | ERN1 | 2.16664324 |
| 20 | LATS1 | 2.06575387 |
| 21 | TBK1 | 2.05178321 |
| 22 | KDR | 2.00976884 |
| 23 | IRAK4 | 1.98481876 |
| 24 | STK38L | 1.95605715 |
| 25 | ZAP70 | 1.93038372 |
| 26 | TAOK3 | 1.92181069 |
| 27 | BCKDK | 1.92050487 |
| 28 | PNCK | 1.86657970 |
| 29 | WNK3 | 1.85895228 |
| 30 | TYK2 | 1.85390531 |
| 31 | MAPK13 | 1.84482191 |
| 32 | TXK | 1.83103801 |
| 33 | KIT | 1.76949725 |
| 34 | ARAF | 1.74189003 |
| 35 | CASK | 1.74013245 |
| 36 | MAP4K2 | 1.72274918 |
| 37 | OXSR1 | 1.68824690 |
| 38 | NUAK1 | 1.68327602 |
| 39 | EIF2AK3 | 1.64433997 |
| 40 | MAP3K11 | 1.62851778 |
| 41 | TGFBR1 | 1.58831856 |
| 42 | DAPK2 | 1.58072394 |
| 43 | STK39 | 1.57447030 |
| 44 | TESK1 | 1.49554059 |
| 45 | RPS6KA4 | 1.48006314 |
| 46 | NTRK3 | 1.45604388 |
| 47 | ADRBK1 | 1.42477316 |
| 48 | LRRK2 | 1.38530061 |
| 49 | JAK3 | 1.38158606 |
| 50 | IKBKE | 1.35195845 |
| 51 | IKBKB | 1.34016420 |
| 52 | ACVR1B | 1.28365141 |
| 53 | MKNK2 | 1.27331119 |
| 54 | NEK2 | 1.25272147 |
| 55 | MAPK15 | 1.24804554 |
| 56 | MARK1 | 1.21869662 |
| 57 | EPHA2 | 1.19784858 |
| 58 | MAP3K4 | 1.17325669 |
| 59 | ABL2 | 1.16033505 |
| 60 | MAPKAPK3 | 1.13488490 |
| 61 | MAP2K2 | 1.12861488 |
| 62 | AKT3 | 1.05953664 |
| 63 | FLT3 | 1.04958681 |
| 64 | CSF1R | 1.04841394 |
| 65 | PRKCG | 1.00560601 |
| 66 | PLK4 | 0.99522359 |
| 67 | MAP3K13 | 0.97479125 |
| 68 | PIK3CA | 0.95049922 |
| 69 | BRSK2 | 0.94919902 |
| 70 | SYK | 0.94412664 |
| 71 | PIM1 | 0.94262915 |
| 72 | PAK3 | 0.94148137 |
| 73 | BRAF | 0.93976262 |
| 74 | NME1 | 0.92671438 |
| 75 | MOS | 0.92441270 |
| 76 | MAP3K14 | 0.90381668 |
| 77 | CAMK1D | 0.89684202 |
| 78 | MARK3 | 0.89391224 |
| 79 | VRK1 | 0.88577039 |
| 80 | PRKCE | 0.88134008 |
| 81 | PBK | 0.88079104 |
| 82 | STK3 | 0.88009440 |
| 83 | GRK6 | 0.87816486 |
| 84 | FGFR4 | 0.86841304 |
| 85 | STK10 | 0.86782990 |
| 86 | DYRK3 | 0.83091458 |
| 87 | MAP3K8 | 0.82343380 |
| 88 | BTK | 0.80049462 |
| 89 | MAP2K3 | 0.79672825 |
| 90 | LYN | 0.79513442 |
| 91 | TTK | 0.78959198 |
| 92 | IRAK2 | 0.78013141 |
| 93 | PLK1 | 0.77754007 |
| 94 | LCK | 0.77300697 |
| 95 | PIK3CG | 0.76740845 |
| 96 | CSNK1A1L | 0.76359104 |
| 97 | CAMK1G | 0.75818768 |
| 98 | TLK1 | 0.75391478 |
| 99 | KSR2 | 0.75211089 |
| 100 | PRKAA2 | 0.74996518 |
| 101 | MAP3K3 | 0.73803348 |
| 102 | PHKG1 | 0.73649169 |
| 103 | PHKG2 | 0.73649169 |
| 104 | IRAK1 | 0.72315533 |
| 105 | MAPKAPK5 | 0.72281977 |
| 106 | PAK1 | 0.71531837 |
| 107 | CDK7 | 0.68835789 |
| 108 | TRIB3 | 0.68740436 |
| 109 | PRKG2 | 0.68022813 |
| 110 | CSNK1G2 | 0.66953691 |
| 111 | MAP2K6 | 0.65619020 |
| 112 | TRPM7 | 0.65281424 |
| 113 | PAK4 | 0.63720852 |
| 114 | RIPK4 | 0.63321972 |
| 115 | TIE1 | 0.63057429 |
| 116 | AURKB | 0.62348712 |
| 117 | AURKA | 0.62159755 |
| 118 | MAP2K7 | 0.61736057 |
| 119 | CDK4 | 0.61521677 |
| 120 | TSSK6 | 0.61419739 |
| 121 | TEC | 0.61264604 |
| 122 | PTK2B | 0.60703126 |
| 123 | CAMKK2 | 0.60399816 |
| 124 | PASK | 0.59746897 |
| 125 | CHUK | 0.59397407 |
| 126 | MST4 | 0.58630212 |
| 127 | TNIK | 0.57844693 |
| 128 | NEK1 | 0.56557867 |
| 129 | MATK | 0.56307650 |
| 130 | WNK1 | 0.55657986 |
| 131 | CAMK2A | 0.55575295 |
| 132 | LIMK1 | 0.54283705 |
| 133 | STK38 | 0.53291167 |
| 134 | PKN1 | 0.51053980 |
| 135 | RPS6KB2 | 0.50327222 |
| 136 | STK4 | 0.49866215 |
| 137 | CDK19 | 0.49519180 |
| 138 | GRK7 | 0.48543508 |
| 139 | PRKCI | 0.48475679 |
| 140 | CSNK2A1 | 0.48223395 |
| 141 | ILK | 0.47740569 |
| 142 | CSNK1G1 | 0.47234117 |
| 143 | RPS6KA5 | 0.47211188 |
| 144 | OBSCN | 0.46851556 |
| 145 | TAF1 | 0.46510456 |
| 146 | STK11 | 0.46302082 |
| 147 | CSNK1G3 | 0.45584505 |
| 148 | BRSK1 | 0.45198104 |
| 149 | CSK | 0.44571331 |
| 150 | DYRK2 | 0.43675041 |
| 151 | JAK1 | 0.43300165 |
| 152 | CAMK1 | 0.43026824 |
| 153 | PINK1 | 0.42967875 |
| 154 | PRKAA1 | 0.42831847 |
| 155 | PRKACA | 0.42788981 |
| 156 | HCK | 0.42375203 |
| 157 | CSNK2A2 | 0.42308809 |
| 158 | PRKCQ | 0.42259551 |
| 159 | NLK | 0.42161331 |
| 160 | RPS6KA6 | 0.42112446 |
| 161 | NTRK2 | 0.41604496 |
| 162 | PRKCD | 0.41237569 |
| 163 | MKNK1 | 0.40953840 |
| 164 | RAF1 | 0.39198558 |
| 165 | CSNK1D | 0.38710956 |
| 166 | JAK2 | 0.38463385 |
| 167 | MAP2K1 | 0.37839849 |
| 168 | DAPK3 | 0.35731528 |
| 169 | MELK | 0.34870432 |
| 170 | CSNK1A1 | 0.34823780 |
| 171 | PLK2 | 0.34212168 |
| 172 | CHEK2 | 0.33957969 |
| 173 | ATR | 0.33834525 |
| 174 | PRKCZ | 0.33091987 |
| 175 | SGK2 | 0.32162991 |
| 176 | PRKACB | 0.30693309 |
| 177 | PRKCA | 0.30333986 |
| 178 | ITK | 0.29248456 |
| 179 | PRKCH | 0.28704961 |
| 180 | SIK2 | 0.27186980 |
| 181 | MUSK | 0.25419920 |
| 182 | ERBB2 | 0.24117762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.51023344 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.18873060 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.72012545 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.71283120 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.66365407 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.64450833 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59168473 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.58190324 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.57581917 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.56793144 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45908487 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.40218046 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33968310 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.30292955 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.26301432 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23061753 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 2.10913736 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 2.07990078 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.03100693 |
| 20 | Protein export_Homo sapiens_hsa03060 | 2.02253172 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.93496411 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.92392441 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91616335 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.89500857 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.86532291 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.82537383 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.80354935 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.80161009 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.74160373 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72292767 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68892575 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.67815893 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.67503271 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.65032623 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60590149 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.60333262 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59202034 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56670300 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55837820 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.53828596 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.53415964 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53104128 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53072141 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51376003 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.48160981 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42113194 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38818117 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35927493 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.34014328 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32007397 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.29953465 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28984531 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20984598 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18307797 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17943940 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.17576397 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17372179 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 1.14310187 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13995509 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13332361 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12425173 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11779701 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09078040 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08031436 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07243584 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07228624 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06527375 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06034292 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04867453 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04467797 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 1.03634721 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03619256 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03031419 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02578694 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99588712 |
| 76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99408865 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.97721584 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97324083 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97039361 |
| 80 | Insulin secretion_Homo sapiens_hsa04911 | 0.96819377 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93582072 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93516724 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92359756 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91931541 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87812247 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86558634 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85950940 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85156215 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84381844 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.81854654 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80988885 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80876959 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80351536 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80220320 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79818225 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.79699223 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.78740259 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78683002 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77950535 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76846915 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76498708 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75924800 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.75660856 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.73928946 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73427845 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73180511 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73144925 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72467849 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.71172797 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71117429 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69902074 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69623455 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68734318 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.67645599 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67246235 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67222778 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.67170459 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66690048 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66276087 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65501548 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65446111 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.65236002 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64759257 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.64229603 |
| 125 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64034334 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63982823 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62690713 |
| 128 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62494000 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60612135 |
| 130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60139021 |
| 131 | Lysine degradation_Homo sapiens_hsa00310 | 0.59815176 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58078979 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.57381022 |
| 134 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57288633 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.57039226 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56753865 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54595567 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.53005072 |
| 139 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51255905 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50569773 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.50129417 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49774434 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46980710 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46628336 |
| 145 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46499905 |
| 146 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45135974 |
| 147 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43225181 |
| 148 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43191858 |
| 149 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43011726 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42630959 |
| 151 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42139364 |
| 152 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42110670 |
| 153 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41811782 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41563131 |
| 155 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41026191 |
| 156 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39610776 |
| 157 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38317427 |
| 158 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36571822 |
| 159 | Long-term depression_Homo sapiens_hsa04730 | 0.36055767 |
| 160 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35816236 |
| 161 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34624755 |
| 162 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33842090 |
| 163 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29913862 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29866206 |
| 165 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28303784 |

